| 引用本文:刘巧红1，3，赵瑜1,3，胡义扬1,2,3.调节肠道菌群治疗非酒精性脂肪肝的研究进展[J].世界中医药,2020,(07):. |
|
| 调节肠道菌群治疗非酒精性脂肪肝的研究进展 |
| Research Progress of Intestinal Microbiota Regulation in the Treatment of Nonalcoholic Fatty Liver |
| 投稿时间：2019-08-28 |
| DOI：10.3969/j.issn.1673-7202.2020.07.024 |
| 中文关键词: 肠道菌群 非酒精性脂肪性肝病 研究进展 益生菌 抗生素 黏附分子 肠菌移植 中药 |
| English Keywords:Intestinal microbiota Non-alcoholic fatty liver disease Research progress Probiotics Antibiotics Adhesion molecules Enterobacteria transplantation Traditional Chinese medicine |
| 基金项目:国家自然科学基金重点项目（81830119）;上海申康三年行动计划（16CR1019A） |
|
| 摘要点击次数: 545 |
| 全文下载次数: 0 |
| 中文摘要: |
| 近年来的研究表明，肠道微生物群的生态失调、炎性反应和黏膜免疫功能受损是NAFLD发生发展的重要因素。调节肠道菌群是治疗非酒精性脂肪肝的重要策略和治疗靶位之一，具有良好的前景。现综述通过调节肠道菌群治疗非酒精性脂肪肝的研究进展，如益生菌、抗生素、黏附分子、肠菌移植，以及中医药在非酒精性脂肪肝中的应用研究。 |
| English Summary: |
| Recent studies have shown that ecological imbalance of intestinal microbiota,inflammation and impaired mucosal immune function are important factors for the occurrence and development of NAFLD.This paper reviews the research progress in the treatment of non-alcoholic fatty liver by regulating intestinal microbiota,such as probiotics,antibiotics,adhesion molecules,intestinal bacteria transplantation,and the application of traditional Chinese medicine in non-alcoholic fatty liver.The authors believes that the regulation of intestinal microbiota is one of the important strategies and targets for the treatment of non-alcoholic fatty liver and has a good prospect. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
